NOVARTIND.BO
Price:
$784.35
Market Cap:
$19.37B
Novartis India Limited operates as a healthcare company in India. It offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands; and neurosciences products under the Tegrital and Exelon brands. The company was incorporated in 1947 and is based in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2000-01-03
Stock Exchange
BSE
Ticker
NOVARTIND.BO
According to Novartis India Limited’s latest financial reports and current stock price. The company's current ROE is 13.87%. This represents a change of 300.08% compared to the average of 3.47% of the last 4 quarters.
The mean historical ROE of Novartis India Limited over the last ten years is 8.18%. The current 13.87% ROE has changed 69.65% with respect to the historical average. Over the past ten years (40 quarters), NOVARTIND.BO's ROE was at its highest in in the June 2022 quarter at 7.57%. The ROE was at its lowest in in the March 2022 quarter at -3.38%.
Average
8.18%
Median
8.75%
Minimum
-0.54%
Maximum
16.61%
Discovering the peaks and valleys of Novartis India Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 116.96%
Maximum Annual ROE = 16.61%
Minimum Annual Increase = -2577.74%
Minimum Annual ROE = -0.54%
| Year | ROE | Change |
|---|---|---|
| 2025 | 12.85% | 12.38% |
| 2024 | 11.44% | -14.17% |
| 2023 | 13.33% | -2577.74% |
| 2022 | -0.54% | -118.30% |
| 2021 | 2.94% | 110.12% |
| 2020 | 1.40% | -79.49% |
| 2019 | 6.82% | -36.16% |
| 2018 | 10.68% | 71.66% |
| 2017 | 6.22% | -62.55% |
| 2016 | 16.61% | 116.96% |
The current ROE of Novartis India Limited (NOVARTIND.BO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
12.54%
5-year avg
8.00%
10-year avg
8.18%
Novartis India Limited’s ROE is less than Amrutanjan Health Care Limited (17.47%), less than Amrutanjan Health Care Limited (17.47%), less than Windlas Biotech Limited (13.35%), less than Windlas Biotech Limited (13.35%), less than Morepen Laboratories Limited (8.12%), less than Morepen Laboratories Limited (8.12%), less than Bliss GVS Pharma Limited (10.14%), less than Bliss GVS Pharma Limited (10.14%), less than Alembic Limited (13.81%), less than Megasoft Limited (76.89%),
| Company | ROE | Market cap |
|---|---|---|
| 17.47% | $19.00B | |
| 17.47% | $18.96B | |
| 13.35% | $16.12B | |
| 13.35% | $16.15B | |
| 8.12% | $23.27B | |
| 8.12% | $23.24B | |
| 10.14% | $18.10B | |
| 10.14% | $18.08B | |
| 13.81% | $25.90B | |
| 76.89% | $14.72B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novartis India Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Novartis India Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Novartis India Limited's ROE?
How is the ROE calculated for Novartis India Limited (NOVARTIND.BO)?
What is the highest ROE for Novartis India Limited (NOVARTIND.BO)?
What is the 3-year average ROE for Novartis India Limited (NOVARTIND.BO)?
What is the 5-year average ROE for Novartis India Limited (NOVARTIND.BO)?
How does the current ROE for Novartis India Limited (NOVARTIND.BO) compare to its historical average?